Amgen in den Nachrichten
Entwicklung innovativer Humantherapeutika
Tamtam hat 20 aktuelle Artikel über Amgen gefunden.
- How Investors Are Reacting To Amgen (AMGN) Earnings Beat
- Amgen Inc. stock outperforms competitors on strong trading day
- Amgen announces Sjogren's trial results: Amgen stock gains 1.59 percent
- Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis
- Truist raises Amgen stock price target to $380 on pipeline growth
- Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, Truist Financial Analyst Says
- Amgen (AMGN) Advances While Market Declines: Some Information for Investors
- Ada Visa Joins Amgen as Global Development Scientist Director
- Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
- 3,524 Amgen Inc. $AMGN Shares Sold by Colton Groome Financial Advisors LLC
- Amgen stock faces a USD 400 Cantor Fitzgerald target
- 2,546 Amgen Inc. $AMGN Shares Sold by Argent Capital Management LLC
- Why is Amgen (NASDAQ:AMGN) stock in focus as its obesity pipeline advances?
- Cantor Fitzgerald reiterates Amgen stock Neutral rating at $400 By Investing.com
- David J. Taylor Purchases Amgen and Home Depot Stocks, Sells Marathon Petroleum
- Amgen (NASDAQ:AMGN) Stock Purchase Disclosed by Rep. David Taylor
- Ohio Rep. David Taylor Bought Up to $45K Worth of Amgen Stock
- The biotech process development associate in Amgen’s grad programme
- Amgen (NASDAQ:AMGN) Scores Late-Stage Immunology Win
- More Than Skin Deep: Understanding Discoid Lupus Erythematosus
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie Amgen?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden